Cemindo Gemilang Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cemindo Gemilang Tbk. trades at Rp790 (market cap 13.53T, 18.83M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 82.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Cemindo Gemilang Tbk. is more actively traded (18.83M versus 43.9K). Which is the better fit depends on your goals.
| CMNT | OBAT | |
|---|---|---|
Market Cap | 13.53T | 164.65B |
Volume | 18.83M | 43.9K |
Lot | 188.3K | 439 |
Turnover | 14.85B | 10.6M |
Average Price | 788.52 | 241.43 |
Value | 14.85B | 10.6M |
Indicative Equilibrium Price | 800 | 238 |
Indicative Equilibrium Volume | 1 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.
Read more on CMNT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →